South Africa is reviving its nuclear fuel industry with a new uranium enrichment facility, marking a return to a sector abandoned over 30 years ago.
South Africa's nuclear revival begins
South Africa, the only African country producing nuclear electricity, is exploring new opportunities in nuclear fuel manufacturing through the development of advanced reactors. This effort could mark the country’s return to an activity it abandoned over thirty years ago.New agreement signed for uranium enrichment
On Thursday, October 15, American company Quantum Leap Energy and South African public company Necsa signed a binding framework agreement to develop a uranium enrichment facility at the Pelindaba site, near Pretoria. The project involves creating a joint venture with Quantum Leap Energy holding about 80 percent and Necsa about 20 percent.Facility aims to produce advanced nuclear fuel
The future plant is expected to produce HALEU, a type of uranium enriched to more than 5 percent and less than 20 percent. This material is used as fuel in some advanced nuclear reactors and is in demand by companies like TerraPower, which is developing new generation reactors.Historical context of South Africa’s nuclear industry
According to the World Nuclear Association, South Africa once had an enrichment facility called Z-Plant, which supplied the Koeberg nuclear power plant. The facility closed in 1995 due to economic reasons, and since then, Eskom has sourced its enrichment and fuel manufacturing from the international market.Government supports nuclear fuel cycle development
The project aligns with the South African government’s industrial ambitions. In October 2025, the Minister of Electricity and Energy announced plans to develop local activities in the nuclear fuel cycle, beyond just electricity production. This agreement represents a step forward in that direction.Challenges remain for the project
While the agreement with Quantum Leap Energy is a significant step, the cost of the installation and its commissioning schedule are still to be determined. The partners must also continue testing and obtain necessary approvals before moving toward commercial production.
